RSK1 Antibody (Rabbit mAb) [P7B9]

Katalognr. F4614

Skriv ut

Biologisk beskrivning

Specificitet RSK1 Antibody (Rabbit mAb) [P7B9] detekterar endogena nivåer av totalt RSK1-protein.
Bakgrund RSK1 (ribosomal S6 kinase 1) är ett serin/treoninkinas som fungerar som en nyckeleffektor i ERK/MAPK-signalvägen och kännetecknas av sina två kinasdomäner: en N-terminal kinasdomän (NTKD) och en C-terminal kinasdomän (CTKD). NTKD har en bilobal veckning med en oordnad aktiveringsloop och αC-helix i sin inaktiva form, medan CTKD innehåller en ERK-docknings-D-domän och kritiska fosforyleringsställen (Thr573/Ser380 i CTKD, Thr359/Ser363 i linker-regionen). Aktivering av RSK1 sker sekventiellt: ERK1/2 dockar först vid D-domänen för att fosforylera CTKD Thr573, vilket sedan utlöser autofosforylering vid NTKD:s hydrofoba motiv Ser380 och PDK1-medierad fosforylering vid Thr359/Ser363, vilket inriktar katalytiska spines och exponerar NTKD:s aktiva säte för substratåtkomst. Fullt aktiverat RSK1 utnyttjar ett C-terminalt dockningsmotiv för att rekrytera substrat, där NTKD fosforylerar mål som S6 Kinase (vilket förbättrar 5'TOP mRNA-translation och ribosombiogenes), Mcl-1/Mdm2 (vilket främjar anti-apoptotisk Bcl-2-stabilisering och p53-nedbrytning), TSC2/raptor (vilket aktiverar mTORC1 för att stimulera proteinsyntes) och cytoskeletala effektorer som filamin A, LIMK och cofilin (vilket driver aktin-remodellering för cellmotilitet och invasion). PI3K/mTOR-signalering ger ytterligare input vid Ser380, vilket förstärker tillväxtfaktorstyrda svar, medan negativ reglering medieras av PP2C/PP1-fosfataser och S100B-hämning vid ERK-dockningsgränssnittet. Hyperaktivering av RSK1 är involverad i cancerprogression, inklusive bröst-, prostata- och kolorektalcancer, genom att förbättra proliferation, överlevnad, metastasering och kemoresistens, och är kopplad till dålig prognos genom NF-κB/STAT3-crosstalk, samt till insulinresistens och hjärthypertrofi.

Användningsinformation

Applikation WB, IP Utspädning
WB IP
1:1000 1:50
Reaktivitet Human, Mouse, Rat, Monkey, Bovine, Pig
Källa Rabbit Monoclonal Antibody MW 90 kDa
Lagringsbuffert PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Lagring
(Från mottagningsdatumet)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail), sonicate to lyse the cells, and incubate on ice for 30 minutes.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail), sonicate to lyse the cells, and incubate on ice for 30 minutes.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Referenser

  • https://pubmed.ncbi.nlm.nih.gov/26527685/
  • https://pubmed.ncbi.nlm.nih.gov/25730857/

Applikationsdata

WB

Validerad av Selleck

  • F4614-wb
    Lane 1: A431, Lane 2: K562, Lane 3: Jurkat, Lane 4: COS-7